ITOC
Company Description
iTonic Holdings Ltd., a healthcare solutions firm, specializes in the development and commercialization of software and devices for brachytherapy. Its advanced proprietary treatment planning system centers on radioactive particle implantation, a form of radiotherapy employed in cancer treatment to precisely position radioactive sources within patients, thereby eradicating malignant cells and reducing tumor size. Key among its offerings is FTTPS, a sophisticated treatment planning system engineered for diverse malignant tumors. This system excels at defining the target volume, determining the prescribed dose, establishing safety margins for organs at risk, and formulating a precise dose distribution plan essential for brachytherapy patients. Founded in Beijing, China, in 1998, the company operated as Pheton Holdings Ltd. until its rebranding to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. functions as a subsidiary of ZJW (BVI) LTD.
Track Record
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 523,031 | 448,196 | 628,591 | 679,777 | 702,776 |
| Net Income | (5.10M) | (660,588) | (241,217) | 83,980 | 192,462 |
| EPS | -0.32 | -0.05 | -0.02 | 0.01 | 0.01 |
| Free Cash Flow | (3.24M) | (775,860) | (63,640) | (116,150) | 80,770 |
| FCF / Share | -0.20 | -0.06 | -0.00 | -0.01 | 0.01 |
| Operating CF | (3.24M) | (775,000) | (63,636) | (116,152) | 80,765 |
| Total Assets | 9.10M | 6.72M | 1.62M | 1.40M | 1.33M |
| Total Debt | 142,998 | 247,969 | 155,818 | 218,326 | 297,400 |
| Cash & Equiv | 1.49M | 6.16M | 227,450 | 72,288 | 136,750 |
| Book Value | 6.12M | 6.18M | 306,272 | 556,322 | 954,342 |
| Return on Equity | -0.83 | -0.11 | -0.79 | 0.15 | 0.20 |
| Metric | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 455,524 | 67,507 | 237,708 | 210,488 | 361,803 | 266,788 | 292,516 | 387,261 |
| Net Income | (3.06M) | (2.04M) | (375,456) | (285,132) | (157,618) | (83,599) | 12,390 | 71,590 |
| EPS | -0.18 | -0.14 | -0.03 | -0.02 | -0.01 | -0.01 | 0.00 | 0.00 |
| Free Cash Flow | (405,120) | (2.84M) | N/A | N/A | (32,740) | (30,890) | 43,980 | (160,130) |
| FCF / Share | -0.02 | -0.19 | N/A | N/A | -0.00 | -0.00 | 0.00 | -0.01 |
| Operating CF | (404,055) | (2.84M) | N/A | N/A | (32,743) | (30,893) | 43,976 | (160,129) |
| Total Assets | 9.10M | 5.11M | 6.72M | 1.36M | 1.62M | 1.45M | 1.40M | N/A |
| Total Debt | 142,998 | 139,595 | 247,969 | 377,647 | 155,818 | 184,648 | 218,326 | N/A |
| Cash & Equiv | 1.49M | 1.81M | 6.16M | 27,206 | 227,450 | 33,494 | 72,288 | N/A |
| Book Value | 6.12M | 4.73M | 6.18M | 16,173 | 306,272 | 454,451 | 556,322 | N/A |
| Return on Equity | -0.50 | -0.43 | -0.06 | -17.63 | -0.51 | -0.18 | 0.02 | N/A |
